CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-21 | Khwaja Omar | Sale | −3,516 | $4.03 | $14K | 120,509 |
| 2021-04-05 | Hesslein Robert W. Senior VP & General Counsel | Sale | +3,292 | $4.95 | $16K | 110,056 |
| 2021-03-19 | Khwaja Omar | Grant or award | +35,000 | 124,025 | ||
| 2021-03-19 | Hesslein Robert W. Senior VP & General Counsel | Grant or award | +30,000 | 113,348 | ||
| 2021-03-19 | Turenne Andre President & CEO | Grant or award | +80,000 | 322,375 | ||
| 2021-03-19 | Dorval Allison Chief Financial Officer | Grant or award | +30,000 | 109,894 | ||
| 2021-02-16 | Turenne Andre President & CEO | Grant or award | +94,000 | 242,375 | ||
| 2021-02-16 | Turenne Andre President & CEO | Grant or award · Stock Option (Right to Buy) | +189,000 | 189,000 | ||
| 2021-02-16 | Khwaja Omar | Grant or award | +36,000 | 89,025 | ||
| 2021-02-16 | Khwaja Omar | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2021-02-16 | Hesslein Robert W. Senior VP & General Counsel | Grant or award | +34,000 | 83,348 | ||
| 2021-02-16 | Hesslein Robert W. Senior VP & General Counsel | Grant or award · Stock Option (Right to Buy) | +68,000 | 68,000 | ||
| 2021-02-16 | Dorval Allison Chief Financial Officer | Grant or award | +34,000 | 79,894 | ||
| 2021-02-16 | Dorval Allison Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +68,000 | 68,000 | ||
| 2021-02-11 | Turenne Andre President & CEO | Sale | −7,977 | $7.55 | $60K | 148,375 |
| 2021-02-11 | Dorval Allison Chief Financial Officer | Sale | −3,186 | $7.55 | $24K | 45,894 |
| 2021-02-11 | Hesslein Robert W. Senior VP & General Counsel | Sale | −3,186 | $7.55 | $24K | 49,348 |
| 2021-02-11 | Khwaja Omar | Sale | −3,475 | $7.55 | $26K | 53,025 |
| 2021-01-12 | Turenne Andre President & CEO | Sale | −10,443 | $8.62 | $90K | 156,352 |
| 2021-01-12 | Dorval Allison Chief Financial Officer | Sale | −2,942 | $8.62 | $25K | 49,080 |
Page 12 of 19 · 368 trades